Derivados selenados como terapia frente a cáncer, tripanosomas y otras patologías
SECALE
Universidad de Zaragoza
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Zaragoza (8)
2017
-
The Use of Fluoroproline in MUC1 Antigen Enables Efficient Detection of Antibodies in Patients with Prostate Cancer
Journal of the American Chemical Society, Vol. 139, Núm. 50, pp. 18255-18261
2016
-
Bifunctional Chiral Dehydroalanines for Peptide Coupling and Stereoselective S-Michael Addition
Organic Letters, Vol. 18, Núm. 12, pp. 2796-2799
-
Design of α-S-Neoglycopeptides Derived from MUC1 with a Flexible and Solvent-Exposed Sugar Moiety
Journal of Organic Chemistry, Vol. 81, Núm. 14, pp. 5929-5941
-
Mucin Architecture behind the Immune Response: Design and Evaluation of an Antitumor Vaccine Derived from an Unnatural MUC1 Fragment
Chemical Science, Vol. 7, Núm. 3, pp. 2294
-
Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents
Nature Communications, Vol. 7
-
Tn Antigen Mimics Based on sp2-Iminosugars with Affinity for an anti-MUC1 Antibody
Organic Letters, Vol. 18, Núm. 15, pp. 3890-3893
2015
-
Deciphering the Non-Equivalence of Serine and Threonine O-glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody
Angewandte Chemie International, Vol. 54, Núm. 34, pp. 9830
2014
-
Serine versus Threonine Glycosylation witha-O-GalNAc: Unexpected Selectivity in Their Molecular Recognition with Lectins
Chemistry - A European Journal, Vol. 20, Núm. 39, pp. 12616-12627